{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:54:08Z","timestamp":1696294448693},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.transproceed.2010.03.044","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T01:56:14Z","timestamp":1275011774000},"page":"1325-1328","source":"Crossref","is-referenced-by-count":8,"title":["Superior Efficacy of Enteric-coated Mycophenolate vs Mycophenolate Mofetil in De Novo Transplant Recipients: Pooled Analysis"],"prefix":"10.1016","volume":"42","author":[{"given":"M.","family":"Salvadori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Budde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Holzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Civati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Lien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Arns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2010.03.044_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1600-6143.2003.00321.x","article-title":"Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study","volume":"4","author":"Budde","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.03.044_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients","volume":"4","author":"Salvadori","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.03.044_bib3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1600-6143.2006.01693.x","article-title":"Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients","volume":"7","author":"Budde","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.03.044_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug Safety"},{"key":"10.1016\/j.transproceed.2010.03.044_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425255.1.3.505","article-title":"Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability","volume":"1","author":"Shipkova","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.transproceed.2010.03.044_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1399-3062.2007.00237.x","article-title":"Etiologic agents of diarrhea in solid organ recipients","volume":"9","author":"Arslan","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2010.03.044_bib7","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/ndt\/gfi009","article-title":"Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium","volume":"20","author":"Kamar","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2010.03.044_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.tp.0000225760.09969.1f","article-title":"Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure","volume":"82","author":"Bunnapradist","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.03.044_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1034\/j.1399-0012.2003.00026.x","article-title":"The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation","volume":"17","author":"Pelletier","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2010.03.044_bib10","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","article-title":"Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation","volume":"14","author":"Knoll","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2010.03.044_bib11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/TP.0b013e3181b0e65e","article-title":"Comparing outcomes associated with dose manipulations of enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients","volume":"88","author":"Cooper","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.03.044_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/TP.0b013e3181ca860d","article-title":"Mycophenolate mofetil versus enteric-coated mycophenolate sodium: A large single-center comparison of dose adjustments and outcomes in kidney transplant recipients","volume":"89","author":"Sollinger","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.03.044_bib13","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/01.TP.0000141094.34903.54","article-title":"Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients","volume":"78","author":"Vitko","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.03.044_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000164352.65613.24","article-title":"Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study","volume":"80","author":"Lorber","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.03.044_bib15","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.transproceed.2007.03.064","article-title":"Efficacy and safety of enteric-coated mycophenolate sodium in de novo renal transplant recipients: pooled data from three 12-month multicenter, open-label, prospective studies","volume":"39","author":"Legendre","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.03.044_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.transproceed.2006.10.216","article-title":"Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable maintenance renal transplant patients: pooled results from three international, multicenter studies","volume":"39","author":"Pietruck","year":"2007","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510003325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510003325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T16:21:36Z","timestamp":1544458896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134510003325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0041134510003325"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.03.044","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}